{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:38:08Z","timestamp":1781663888664,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thymic Epithelial Tumors (TETs), the most common tumors in the anterior mediastinum in adults, show a unique association with autoimmune Myasthenia Gravis (MG) and represent a multidisciplinary diagnostic and therapeutic challenge. Neither risk factors nor established biomarkers for TETs exist. Predictive and diagnostic markers are urgently needed. Heat shock proteins (HSPs) are upregulated in several malignancies promoting tumor cell survival and metastases. We performed immunohistochemical staining of HSP27 and 70 in patients with TETs (n\u2009=\u2009101) and patients with benign thymic alterations (n\u2009=\u200924). Further, serum HSP27 and 70 concentrations were determined in patients with TETs (n\u2009=\u200946), patients with benign thymic alterations (n\u2009=\u200933) and volunteers (n\u2009=\u200949) by using ELISA. HSPs were differentially expressed in histologic types and pathological tumor stages of TETs. Weak HSP tumor expression correlated with worse freedom from recurrence. Serum HSP concentrations were elevated in TETs and MG, correlated with clinical tumor stage and histologic subtype and decreased significantly after complete tumor resection. To conclude, we found HSP expression in the vast majority of TETs, in physiologic thymus and staining intensities in patients with TETs have been associated with prognosis. However, although interesting and promising the role of HSPs in TETs as diagnostic and prognostic or even therapeutic markers need to be further evaluated.<\/jats:p>","DOI":"10.1038\/srep24267","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T09:26:12Z","timestamp":1461230772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications"],"prefix":"10.1038","volume":"6","author":[{"given":"S.","family":"Janik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"BFsrep24267_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK De Jong","year":"2008","unstructured":"De Jong, W. K. et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44, 123\u201330 (2008).","journal-title":"Eur J Cancer"},{"key":"BFsrep24267_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1378\/chest.128.4.2893","volume":"128","author":"BV Duwe","year":"2005","unstructured":"Duwe, B. V., Sterman, D. H. & Musani, A. I. Tumors of the mediastinum. Chest 128, 2893\u2013909 (2005).","journal-title":"Chest"},{"key":"BFsrep24267_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","volume":"35","author":"P Str\u00f6bel","year":"2005","unstructured":"Str\u00f6bel, P., Marx, A., Zettl, A. & M\u00fcller-Hermelink, H. K. Thymoma and thymic carcinoma: an update of the WHO classification 2004. Surg Today 35, 805\u2013811 (2005).","journal-title":"Surg Today"},{"key":"BFsrep24267_CR4","first-page":"17","volume":"115","author":"S Suster","year":"2001","unstructured":"Suster, S. & Moran, C. A. Neuroendocrine neoplasms of the mediastinum. Am J Clin Pathol 115, 17\u201327 (2001).","journal-title":"Am J Clin Pathol"},{"key":"BFsrep24267_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/gcc.22183","volume":"53","author":"P Str\u00f6bel","year":"2014","unstructured":"Str\u00f6bel, P. et al. Tumor genetics and survival of thymic neuroendrocrine neoplasms: a multi-Institutional clinicopathologic study. Genes, Chromosomes & Cancer 53, 738\u2013749 (2014).","journal-title":"Genes, Chromosomes & Cancer"},{"key":"BFsrep24267_CR6","unstructured":"Marx, A. et al. Thymic Neuroendocrine Tumours. World Health Organization Classification Of Tumours. Pathology And Genetics Of Tumours Of The Lung, Pleura, Thymus And Heart. Lyon: IARC Press 2004, pp. 53\u201358 (2004)."},{"key":"BFsrep24267_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1097\/JTO.0b013e31821e8cff","volume":"6","author":"FC Detterbeck","year":"2011","unstructured":"Detterbeck, F. C., Nicholson, A. G., Kondo, K., Van Schil, P. & C. Moran, The Masaoka-koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol 6, 1710\u201316 (2011).","journal-title":"J Thorac Oncol"},{"key":"BFsrep24267_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels, E. A. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 5, 260\u20135 (2010).","journal-title":"J Thorac Oncol"},{"key":"BFsrep24267_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1155\/1998\/49484","volume":"6","author":"A Marx","year":"1998","unstructured":"Marx, A. et al. Paraneoplastic autoimmunity in thymus tumors. Develop Immunol 6, 129\u2013140 (1998).","journal-title":"Develop Immunol"},{"key":"BFsrep24267_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","volume":"201\u2013202","author":"L Maggi","year":"2008","unstructured":"Maggi, L. et al. Thymoma\u2013associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience. J Neuroimmunol 201\u2013202, 237\u201344 (2008).","journal-title":"J Neuroimmunol"},{"key":"BFsrep24267_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/08916930903555935","volume":"43","author":"A Marx","year":"2010","unstructured":"Marx, A. et al. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 43, 413\u2013427 (2010).","journal-title":"Autoimmunity"},{"key":"BFsrep24267_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtcvs.2014.08.061","volume":"149","author":"PL Filosso","year":"2015","unstructured":"Filosso, P. L. et al. Outcome of primary neuroendocrine tumors of the thymus: A joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases. J Thorac Cardiovasc Surg 149, 103\u2013109 (2015).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFsrep24267_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggiolo","year":"2009","unstructured":"Meriggiolo, M. N. & Sanders, D. B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8, 475\u201390 (2009).","journal-title":"Lancet Neurol"},{"key":"BFsrep24267_CR14","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","volume":"77","author":"FC Detterbeck","year":"2004","unstructured":"Detterbeck, F. C. & Parsons, A. M. Thymic tumors. Ann Thorac Surg 77, 1860\u20139 (2004).","journal-title":"Ann Thorac Surg"},{"key":"BFsrep24267_CR15","unstructured":"Rosai, J. & Levine, G. D. Atlas Of Tumor Pathology. Tumors Of The Thymus. Second series, fascicle 13. Armed Forces Institute of Pathology, Washington, DC (1976)."},{"key":"BFsrep24267_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrc.2012.02.121","volume":"420","author":"B Moser","year":"2012","unstructured":"Moser, B. et al. The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis. Biochem Biophys Res Commun 420, 96\u2013101 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep24267_CR17","doi-asserted-by":"publisher","first-page":"e94118","DOI":"10.1371\/journal.pone.0094118","volume":"9","author":"B Moser","year":"2014","unstructured":"Moser, B. et al. Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. PLos ONE 9(4), e94118 (2014).","journal-title":"PLos ONE"},{"key":"BFsrep24267_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.4161\/auto.7.10.16753","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang, R., Livesey, K. M., Zeh, H. J., Loze, M. T. & Tang, D. Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 7(10), 1256\u20131258 (2011).","journal-title":"Autophagy"},{"key":"BFsrep24267_CR19","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-11-2291","volume":"15","author":"KM Livese","year":"2012","unstructured":"Livese, K. M. et al. p53\/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res 15(72), 1996\u20132005 (2012).","journal-title":"Cancer Res"},{"key":"BFsrep24267_CR20","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.ajpath.2011.08.013","volume":"179","author":"S Li","year":"2011","unstructured":"Li, S. et al. Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide- induced peritonitis in rats. Am J Pathoj 179, 2822\u20132834 (2011).","journal-title":"Am J Pathoj"},{"key":"BFsrep24267_CR21","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.4161\/cc.5.22.3448","volume":"5","author":"C Garrido","year":"2006","unstructured":"Garrido, C. et al. Heat shock protein 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5, 2692\u20132601 (2006).","journal-title":"Cell Cycle"},{"key":"BFsrep24267_CR22","first-page":"89","volume":"1816","author":"AA Khalil","year":"2011","unstructured":"Khalil, A. A., Kabapy, N. F., Deraz, S. F. & Smith, C. Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochem Biophys Acta 1816, 89\u2013104 (2011).","journal-title":"Biochem Biophys Acta"},{"key":"BFsrep24267_CR23","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1016\/S0021-9258(19)38314-0","volume":"165","author":"MJ Schlesinger","year":"1990","unstructured":"Schlesinger, M. J. Heat shock proteins. J Biol Chem 165, 12111\u201312114 (1990).","journal-title":"J Biol Chem"},{"key":"BFsrep24267_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.bi.62.070193.002025","volume":"62","author":"JP Hendrick","year":"1993","unstructured":"Hendrick, J. P. & Hartl, F. U. Molecular chaperone functions of heat shock proteins. Annu Rev Biochem 62, 349\u2013384 (1993).","journal-title":"Annu Rev Biochem"},{"key":"BFsrep24267_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molcel.2010.10.006","volume":"40","author":"K Richter","year":"2010","unstructured":"Richter, K., Haslbeck, M. & Buchner, J. The heat shock response: life on the verge of death. Mol Cell 40, 253\u2013266 (2010).","journal-title":"Mol Cell"},{"key":"BFsrep24267_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1582-4934.2008.00273.x","volume":"12","author":"D Lanneau","year":"2008","unstructured":"Lanneau, D. et al. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12, 743\u2013761 (2008).","journal-title":"J Cell Mol Med"},{"key":"BFsrep24267_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2012.06.003","volume":"325","author":"AR Goloudina","year":"2012","unstructured":"Goloudina, A. R., Demidov, O. N. & Garrido, C. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 325, 117\u2013124 (2012).","journal-title":"Cancer Lett"},{"key":"BFsrep24267_CR28","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1074\/jbc.275.14.10661","volume":"275","author":"S Rousseau","year":"2000","unstructured":"Rousseau, S. et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress activated protein kinase 2 (SAPK2\/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 275, 10661\u201310672 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep24267_CR29","first-page":"777","volume":"5","author":"I Kindas-Mugge","year":"1994","unstructured":"Kindas-Mugge, I. & Trautinger, F. Increased expression of the M (r) 27,000 heat shock protein (hsp27) in in-vitro differentiated normal human keratinocytes. Cell Growth Diff 5, 777\u2013781 (1994).","journal-title":"Cell Growth Diff"},{"key":"BFsrep24267_CR30","first-page":"1165","volume":"20","author":"M Tsuruta","year":"2008","unstructured":"Tsuruta, M. et al. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Onco Rep 20, 1165\u20131606 (2008).","journal-title":"Onco Rep"},{"key":"BFsrep24267_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell, M. J. & Hines, W. S. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17, 320\u2013329 (2011).","journal-title":"Nat Med"},{"key":"BFsrep24267_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"BFsrep24267_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2014.05.045","volume":"158","author":"R Scherz-Shouvai","year":"2014","unstructured":"Scherz-Shouvai, R. et al. The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell 158, 564\u2013578 (2014).","journal-title":"Cell"},{"key":"BFsrep24267_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/BF02048033","volume":"38","author":"AC Lazaris","year":"1995","unstructured":"Lazaris, A. C. et al. Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer. Dis Colon Rectum 38(7), 739\u201345 (1995).","journal-title":"Dis Colon Rectum"},{"key":"BFsrep24267_CR35","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1600-0463.2008.01051.x","volume":"116","author":"A Glaessgen","year":"2008","unstructured":"Glaessgen, A. et al. Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. APMIS 116(10), 888\u201395 (2008).","journal-title":"APMIS"},{"key":"BFsrep24267_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3346\/jkms.2005.20.5.829","volume":"20","author":"M Joo","year":"2005","unstructured":"Joo, M., Chi, J. G. & Lee, H. Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci 20(5), 829\u201334 (2005).","journal-title":"J Korean Med Sci"},{"key":"BFsrep24267_CR37","first-page":"501","volume":"28","author":"E Malusecka","year":"2008","unstructured":"Malusecka, E. et al. Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma. Anticancer Res 28(1B), 501\u20136 (2008).","journal-title":"Anticancer Res"},{"key":"BFsrep24267_CR38","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.4317\/medoral.17007","volume":"16","author":"N Mohtasham","year":"2011","unstructured":"Mohtasham, N. et al. The expression of heat shock proteins 27 and 105 in squamous cell carcinoma of the tongue and relationship with clinicopathological index. Med Oral Pathol Oral Cir Bucal 16(6), e730\u20135 (2011).","journal-title":"Med Oral Pathol Oral Cir Bucal"},{"key":"BFsrep24267_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2015.02.026","volume":"360","author":"GD Lianos","year":"2015","unstructured":"Lianos, G. D. et al. The role of heat shock proteins in cancer. Cancer Lett 360, 114\u20138 (2015).","journal-title":"Cancer Lett"},{"key":"BFsrep24267_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tibs.2006.01.006","volume":"31","author":"SK Calderwood","year":"2006","unstructured":"Calderwood, S. K., Khaleque, M. A., Sawyer, D. B. & Ciocca, D. R. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem 31, 164\u2013172 (2006).","journal-title":"Trends Biochem"},{"key":"BFsrep24267_CR41","first-page":"153","volume":"62","author":"B Moser","year":"2014","unstructured":"Moser, B. et al. Thymomas and thymic carcinomas: prognostic factors and multimodal management. Thora. Cardiovasc Surg 62, 153\u2013160 (2014).","journal-title":"Thora. Cardiovasc Surg"},{"key":"BFsrep24267_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ejcts\/ezt649","volume":"46","author":"E Ruffini","year":"2014","unstructured":"Ruffini, E. et al. European Association of Thoracic Surgeons (ESTS) Thymic Working Group. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 46, 361\u20138 (2014).","journal-title":"Eur J Cardiothorac Surg"},{"key":"BFsrep24267_CR43","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1097\/JTO.0b013e3181f13682","volume":"5","author":"J Huang","year":"2010","unstructured":"Huang, J., Detterbeck, F. C., Wang, Z. & Loehrer, P. J. Standard outcome measures for thymic malignancies. J Thorac Oncol 5, 2017\u20132023 (2010).","journal-title":"J Thorac Oncol"},{"key":"BFsrep24267_CR44","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cca.2012.03.008","volume":"413","author":"M Zimmermann","year":"2012","unstructured":"Zimmermann, M. et al. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta 413(13\u201314), 1115\u201320 (2012).","journal-title":"Clin Chim Acta"},{"key":"BFsrep24267_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/ERC-11-0227","volume":"19","author":"P Mayer","year":"2012","unstructured":"Mayer, P. et al. Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. Endocr Relat Cancer 19, 217\u2013232 (2012).","journal-title":"Endocr Relat Cancer"},{"key":"BFsrep24267_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1677\/ERC-09-0318","volume":"25","author":"JA Gilbert","year":"2010","unstructured":"Gilbert, J. A. et al. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors. Endocr Relat Cancer 25, 623\u2013636 (2010).","journal-title":"Endocr Relat Cancer"},{"key":"BFsrep24267_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.thorsurg.2014.05.007","volume":"24","author":"PO Lausi","year":"2014","unstructured":"Lausi, P. O. et al. Thymic neuroendocrine tumors. Thorac Surg Clin 24, 327\u2013332 (2014).","journal-title":"Thorac Surg Clin"},{"key":"BFsrep24267_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","volume":"114","author":"CA Moran","year":"2000","unstructured":"Moran, C. A. & Suster, S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 114(1), 100\u201310 (2000).","journal-title":"Am J Clin Pathol"},{"key":"BFsrep24267_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/cancers6010042","volume":"6","author":"K Juhasz","year":"2013","unstructured":"Juhasz, K. et al. The complex function of Hsp70 in metastatic cancer. Cancers 6, 42\u201366 (2013).","journal-title":"Cancers"},{"key":"BFsrep24267_CR50","doi-asserted-by":"publisher","first-page":"e0120724","DOI":"10.1371\/journal.pone.0120724","volume":"10","author":"T Schweiger","year":"2015","unstructured":"Schweiger, T. et al. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases. PLos ONE 10(3), e0120724. doi: 10.1371\/journal.pone.0120724 (2015).","journal-title":"PLos ONE"},{"key":"BFsrep24267_CR51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.it.2012.03.005","volume":"33","author":"G Anderson","year":"2012","unstructured":"Anderson, G. & Takahama, Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol 33, 256\u201363 (2012).","journal-title":"Trends Immunol"},{"key":"BFsrep24267_CR52","doi-asserted-by":"publisher","first-page":"728605","DOI":"10.1155\/2012\/728605.","volume":"2012","author":"HD Shukla","year":"2012","unstructured":"Shukla, H. D. & Pitha, P. M. Role of hsp90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis 2012, 728605. doi: 10.1155\/2012\/728605. Epub 2012 Oct 4. (2012).","journal-title":"Autoimmune Dis"},{"key":"BFsrep24267_CR53","doi-asserted-by":"publisher","first-page":"346501","DOI":"10.1155\/2012\/346501.","volume":"2012","author":"C Blasi","year":"2012","unstructured":"Blasi, C., Kim, E. & Knowlton, A. A. Improved metabolic control in diabetes, HSP60, and proinflammatory mediators. Autimmune Dis 2012, 346501. doi: 10.1155\/2012\/346501. Epub 2012 Aug 12 (2012).","journal-title":"Autimmune Dis"},{"key":"BFsrep24267_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/08916934.2013.866104","volume":"47","author":"MJ Mansilla","year":"2014","unstructured":"Mansilla, M. J. et al. Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. Autoimmunity 47, 127\u2013133 (2014).","journal-title":"Autoimmunity"},{"key":"BFsrep24267_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneuroim.2010.04.024","volume":"225","author":"G Helgeland","year":"2010","unstructured":"Helgeland, G. et al. Anti-heat-shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barr\u00e9 syndrome. J Neuroimmunol 225, 180\u2013183 (2010).","journal-title":"J Neuroimmunol"},{"key":"BFsrep24267_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jns.2012.12.025","volume":"333","author":"AI Levinson","year":"2013","unstructured":"Levinson, A. I. Modeling the intrathymic pathogenesis of myasthenia gravis. J Neurol Sci 333(1\u20132), 60\u20137 (2013).","journal-title":"J Neurol Sci"},{"key":"BFsrep24267_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/ijo.2014.2399","volume":"45","author":"X Wang","year":"2014","unstructured":"Wang, X., Chen, M., Zhou, J. & Zhang, X. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol 45(1), 18\u201330 (2014).","journal-title":"Int J Oncol"},{"key":"BFsrep24267_CR58","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bmcl.2013.02.014","volume":"23","author":"JR McConnell","year":"2013","unstructured":"McConnell, J. R. & McAlpine, S. R. Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets. Bioorg Med Chem Lett 23, 1923\u20131928 (2013).","journal-title":"Bioorg Med Chem Lett"},{"key":"BFsrep24267_CR59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1185\/03007995.2012.673480","volume":"28","author":"P Sun","year":"2012","unstructured":"Sun, P. & Garrison, L. P. Retrospective outcomes studies for orphan diseases: challenges and opportunities. Curr Med Res Opin 28, 665\u20137 (2012).","journal-title":"Curr Med Res Opin"},{"key":"BFsrep24267_CR60","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182598a91","volume":"7","author":"MK Bae","year":"2012","unstructured":"Bae, M. K. et al. Clinical outcomes and prognosis of recurrent thymoma management. J Thorac Oncol 7, 1304\u201314 (2012).","journal-title":"J Thorac Oncol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep24267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:42:02Z","timestamp":1672890122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep24267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,26]]}},"alternative-id":["BFsrep24267"],"URL":"https:\/\/doi.org\/10.1038\/srep24267","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]},"assertion":[{"value":"23 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24267"}}